Search Search
Our Mission

Bringing Diagnostics Closer to the Patient

IMMY is committed to addressing the global challenges of delayed, inaccurate, and inaccessible fungal diagnostics by delivering innovative, high-quality solutions that ensure the right information reaches the right people at the right time. We empower healthcare providers to make informed treatment decisions that improve outcomes for patients worldwide. 

Through this commitment, we reduce diagnostic gaps and enhance the speed and precision of fungal disease detection; all while keeping the patient at the center of everything we do

Bridging the Gap

Improving Health and Saving Lives

We take pride in developing reliable, accurate diagnostics that bridge the gap between patients and the treatment they urgently need. By enabling early detection, we help connect patients to proper care sooner, improving outcomes and saving lives. Our mission is to make a lasting global impact by bringing crucial diagnostics closer to those who need them most.

Our Core Values

IMMY's core values shape our leadership's strategic direction and set the standard for how we operate. Employees are expected to uphold these values in their daily work, conducting business with integrity, ethics, and a commitment to excellence.

IMMY-2024-Core Value Icons-White-Humble-v1
Humble

We embrace feedback and recognize areas for growth. We hold ourselves accountable, learning from mistakes to foster continuous improvement. We express gratitude and prioritize collective success over individual recognition. Everyone is treated with dignity, creating an environment of mutual respect and learning.

IMMY-2024-Core Value Icons-White-Driven-v1
Driven

Motivated by a growth mindset, we proactively tackle challenges and seek innovative solutions. We are unafraid to challenge the status quo and envision a better future. With a strong work ethic, persistence, and resilience, we operate with urgency, propelling us toward excellence in everything we do.

IMMY-2024-Core Value Icons-White-Collaborative-v1
Collaborative

We actively engage in group discussions, share expertise, and value diverse perspectives to make informed decisions. We foster trust, build positive relationships, encourage growth, and remain committed to shared goals with a positive mindset. Collaboration drives us to overcome challenges together.

Our Solutions

A New Standard for Fungal Diagnostics

IMMY has earned a global reputation for excellence, leading the way in accurate, affordable, and rapid fungal diagnostics. Our products provide reliable detection for a wide range of fungal pathogens, including Cryptococcus, Aspergillus, Histoplasma, Candida auris, Candida species, Pneumocystis jirovecii, Coccidioides, and Blastomyces, as well as mycobacteria specimen preparation reagents. We offer a comprehensive range of diagnostic platforms—including lateral flow assays (LFAs), enzyme immunoassays (EIA), and polymerase chain reaction (PCR) reagents—designed to enhance infectious disease detection and improve patient outcomes worldwide.

Excellence in Every Test

Delivering Innovation and Quality Service Since 1979

Over

5 mil.

lives impacted every year by
IMMY diagnostics

More than

45 years

of excellence

With

100+

employees dedicated to 1 mission

We are

100%

committed to proving the world's
best fungal diagnostics

I am chief of mycology lab at HC/UFPR. We haved used CrAg LFA and Aspergillus LFA for more than 4 years with excellent performance. We are the reference for diagnosis and treatment of cryptococcosis in our state, therefore we want use CrAgSQ as well. IMMY provides robust tests for diagnosis of fungal infections.
Dr. Regielly Cognialli, PhD
Universidade Federal do Paraná

See the IMPACT for yourself. Learn how IMMY's tests can help in your lab.

At the Special Mycology Laboratory at UNIFESP, led by Dr. Arnaldo Lopes Colombo, we participated in a multi-centric pilot project focused on evaluating lateral flow assays for the rapid detection of Invasive Aspergillosis. This initiative provided valuable insights into the potential for enhancing early diagnosis and treatment outcomes in clinical mycology.

As a researcher specializing in filamentous fungi, particularly from the genera Aspergillus and Fusarium, as well as the order Mucorales, my work is deeply aligned with the advancement of diagnostic tools for fungal infections. Therefore, maintaining close collaboration with IMMY studies is crucial for staying at the forefront of innovation in fungal diagnostics and improving patient care in this field.
Milena Viana Silva
Universidade Federal de São Paulo

See the IMPACT for yourself. Learn how IMMY's tests can help in your lab.

Our Team

Careers

We are driven by a mission to develop tests that give patients the opportunity for a healthier life. Behind every product we create and deliver is a face, a story, a family, a legacy. Every day, our employees have the chance to contribute to something larger—making a real impact on lives around the world.

Start the Conversation

Get in Touch

Inquire for products, connect with IMMY experts in your region,
or submit a request for collaboration.